[1] Dekkers OM, Karavitaki N, Pereira AM.The epidemiology of aggressive pituitary tumors (and its challenges)[J]. Rev Endocr Metab Disord, 2020, 21: 209-212. [2] Xiao Z, Liu Q, Mao F, et al. TNF-alpha-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas[J]. Int J Mol Sci, 2011, 12: 4165-4179. [3] Pangal DJ, Chesney K, Memel Z, et al. Pituitary apoplexy case series: outcomes after endoscopic endonasal transsphenoidal surgery at a single tertiary center[J]. World Neurosurg, 2020, 137: 366-372. [4] Drummond GR, Selemidis S, Griendling KK, et al. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets[J]. Nat Rev Drug Discov, 2011, 10: 453-471. [5] 李晶, 崔宏伟, 杨凌. MicroRNA通过ROS途径对脑胶质瘤调节机制的研究进展[J]. 基础医学与临床, 2020, 40: 1124-1129. [6] Tuo YH, Liu Z, Chen JW, et al. NADPH oxidase inhibitor improves outcome of mechanical reperfusion by suppressing hemorrhagic transformation[J]. J Neurointerv Surg, 2017, 9: 492-498. [7] Antonucci S, Di Lisa F, Kaludercic N.Mitochondrial reactive oxygen species in physiology and disease[J]. Cell Calcium, 2021, 94: 1023-1044. [8] Basuroy S, Bhattacharya S, Leffler C W, et al. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells[J]. Am J Physiol Cell Physiol, 2009, 296: C422-C432. [9] Li N, Zhan X.Mitochondrial dysfunction pathway networks and mitochondrial dynamics in the pathogenesis of pituitary adenomas[J]. Front Endocrinol (Lausanne), 2019, 10: 690.doi: 10.3389/fendo.2019.00690. [10] 田新华, 张俊卿, 陈锷, 等. 显微镜与神经内镜下经单鼻孔蝶窦垂体腺瘤切除术的比较[J]. 中华神经外科杂志, 2007,3: 182-184. [11] Zhang SL, Tang HB, Hu JT, et al. PGAM5-CypD pathway is involved in bromocriptine-induced RIP3/MLKL-dependent necroptosis of prolactinoma cells[J]. Biomed Pharmacother, 2019, 111: 638-648. [12] Wang Y, Pang B, Zhang R, et al. Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway[J]. Drug Des Devel Ther, 2019, 13: 3217-3228. |